Breaking News

Novasep Custom Mfg. Sites Complete FDA Inspections

Three sites in France and Germany pass U.S. FDA inspection

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Novasep’s custom manufacturing sites in France (Mourenx and Le Mans), and Germany (Leverkusen) have passed U.S. FDA inspection, with no 483 form.     Novasep’s manufacturing site in Le Mans, France, produces highly potent cytotoxic active pharmaceutical ingredients (HPAPI) and registered advanced intermediates for commercial and clinical development. The site also provides regulatory and containment evaluation support. It produces paclitaxel, for which Novasep holds a valid Drug Master File an...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters